InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,438.05
(
0.90%
)
Post# of 252431
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: xavierprivas post# 235791

Wednesday, 11/25/2020 1:58:12 PM

Wednesday, November 25, 2020 1:58:12 PM

Post# of 252431

CRDF’s Onvansertib is a small molecule PLK1 inhibitor. Came from Pfizer Italia (currently Nerviano
Medical Sciences) which also developed small molecule blockbusters for Array (recently acquired by Pfizer), Ignyta
(acquired by Roche) and Genentech.



KZIA updated by Edison Research

https://kza.irmau.com/irm/PDF/8b64300e-5cf8-4d7a-8382-81ffc7bf909f/EdisonResearchPhaseIIashowsgoodsafetyconsistentefficacy

Bladerunner



xavierprivas and bladerunner,

Thanks for taking he time to give an overview. I will take a closer look.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up